Current Trends: What to Expect in Funding Negotiations for a New Drug in Spain
In recent years, pharmaceutical funding trends in Spain have evolved due to increasing budget impact concerns aggravated by COVID-19.
| Perspective | Commentary | Healthcare & Life Sciences Pharma & Biotechnology Customer, Product & Market Strategy